Senator slams GlaxoSmithKline over cost of asthma inhalers
Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the issue.Less than two months after GlaxoSmithKline pledged to …